Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TXA127 for Severe COVID-19
NCT04401423Phase 2Completed
- Sponsor
- Columbia University
- Start
- Feb 2021
- Primary completion
- Jun 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of angiotensin-(1-7) in coronavirus disease 2019 (COVID-19), sponsored by Columbia University. Started Feb 2021; status: completed.
02
Drugs
angiotensin-(1-7)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04401423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04401423.